You have 9 free searches left this month | for more free features.

glimepiride

Showing 1 - 25 of 128

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ejection Fraction Trial in Seongnam (Gemigliptin, Glimepiride)

Recruiting
  • Ejection Fraction
  • Seongnam, Gyeonggi, Korea, Republic of
    Seoul National University Bundang Hospital
Dec 22, 2022

Drug Use Trial in Jakarta (Glimepiride, Amaryl®)

Completed
  • Drug Use
  • Jakarta, DKI Jakarta, Indonesia
    PT Pharma Metric Labs
Jul 20, 2022

Chronic Heart Failure, Type 2 Diabetes, Cardiovascular Mortality Trial in Wuhan (Glimepiride)

Completed
  • Chronic Heart Failure
  • +3 more
  • Glimepiride
  • Wuhan, Hubei, China
    Tongji Hospital
Sep 11, 2022

Diabetes, Type 2, Severe Insulin Deficient Diabetes Trial in Beijing (Glimepiride, Sitagliptin)

Recruiting
  • Diabetes Mellitus, Type 2
  • Severe Insulin Deficient Diabetes
  • Beijing, Please Select, China
    Peking University People's Hospital
May 18, 2022

Pre-diabetes, Type 2 Diabetes Trial in Philadelphia (Exenatide, Sitagliptin, Glimepiride)

Completed
  • Pre-diabetes
  • Type 2 Diabetes
  • Philadelphia, Pennsylvania
  • +2 more
May 16, 2022

Type2 Diabetes Trial in Evansville (Bexagliflozin, Metformin, Glimepiride)

Completed
  • Type2 Diabetes Mellitus
  • Evansville, Indiana
    Clinical Research Site
Jul 1, 2021

Diabetes, Cellular Senescence, Sodium-Glucose Transporter 2 Inhibitors Trial in Seoul (SGLT2 inhibitor, Glimepiride)

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • SGLT2 inhibitor
  • Glimepiride
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine
Aug 1, 2023

Diabetic Patients Trial in Damanhur (Omega 3 fatty acids 1000 mg per day + glimepiride 2 mg or 3 mg oral, Glimepiride)

Completed
  • Diabetic Patients
  • Omega 3 fatty acids 1000 mg per day + glimepiride 2 mg or 3 mg oral
  • Glimepiride
  • Damanhūr, El-Bahairah, Egypt
    Damanhour Medical National Institute
Feb 5, 2021

Replication of LEAD-2 Diabetes Trial in Healthcare Claims Data

Completed
  • Diabetes
  • Boston, Massachusetts
    Brigham and Women's Hospital
Dec 16, 2021

Replication of GRADE Diabetes Trial in Healthcare Claims Data

Completed
  • Diabetes
  • Boston, Massachusetts
    Brigham and Women's Hospital
Oct 18, 2021

Diabetes, Type 2 Trial in East Hanover, Nurnberg (vildagliptin, glimepiride, Metformin)

Completed
  • Diabetes Mellitus, Type 2
  • East Hanover, New Jersey
  • +1 more
Dec 11, 2020

Type 2 Diabetes Trial (Glimepiride, Alogliptin 25Mg Tab, Alogliptin-Pioglitazone 25 Mg-15 Mg Oral Tablet)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Glimepiride
  • +2 more
  • (no location specified)
Oct 19, 2020

Type 2 Diabetes Trial in Worldwide (Bexagliflozin, Placebo for Bexagliflozin, Glimepiride)

Completed
  • Type 2 Diabetes Mellitus
  • Birmingham, Alabama
  • +44 more
May 25, 2021

Non-alcoholic Fatty Liver Disease Trial in Kanazawa (Tofogliflozin, Glimepiride)

Completed
  • Non-alcoholic Fatty Liver Disease
  • Kanazawa, Ishikawa, Japan
    Kanazawa University Graduate School of Medical Sciences
Jun 30, 2021

Type2 Diabetes, Cardiovascular Diseases Trial in Ann Arbor (Dapagliflozin, Glimepiride)

Completed
  • Type2 Diabetes
  • Cardiovascular Diseases
  • Ann Arbor, Michigan
    University of Michigan
Oct 21, 2020

Type2 Diabetes Trial in Seoul (Glimepiride, Empagliflozin)

Completed
  • Type2 Diabetes Mellitus
  • Seoul, Korea, Republic of
    Yonsei University College of Medicine, Department of Internal Me
Aug 24, 2020

Type 2 Diabetes Trial in Worldwide (Sotagliflozin (SAR439954), Glimepiride, Metformin)

Completed
  • Type 2 Diabetes Mellitus
  • Sotagliflozin (SAR439954)
  • +3 more
  • Birmingham, Alabama
  • +141 more
Apr 16, 2021

Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Glimepiride)

Completed
  • Diabetes
  • Birmingham, Alabama
  • +83 more
Jun 22, 2020

Type 2 Diabetes Trial in Korea, Republic of (metformin, ipragliflozin, glimepiride)

Terminated
  • Type 2 Diabetes Mellitus
  • Busan, Korea, Republic of
  • +7 more
Apr 12, 2020

Type 2 Diabetes, Cardiovascular Disease Trial in Aurora (Sitagliptin, Glimepiride, Placebo)

Completed
  • Type 2 Diabetes
  • Cardiovascular Disease
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Apr 29, 2019

Diabetes Type 2 Trial in Dresden (Sitagliptin, Glimepiride, Sitagliptin-Placebo)

Terminated
  • Diabetes Mellitus Type 2
  • Dresden, Germany
    GWT-TUD GmbH / Studienzentrum Hanefeld
Oct 19, 2018

Diabetes, Type 2 Trial in Leicester, Birmingham (Canagliflozin, Repaglinide, Pioglitazone)

Completed
  • Diabetes Mellitus, Type 2
  • Leicester, Leicestershire, United Kingdom
  • +1 more
Jan 29, 2020

Diabetes, Type 2 Trial in Korea, Republic of (Dapagliflozin, Glimepiride)

Completed
  • Diabetes Mellitus, Type 2
  • Ansan-si, Korea, Republic of
  • +13 more
Aug 19, 2019

Diabetes, Type 2 Trial in Osaka (Sitagliptin, Glimepiride)

Completed
  • Diabetes Mellitus, Type 2
  • Osaka, Japan
  • +1 more
Apr 4, 2019

Diabetes Type 2 Trial in Hannover (Empagliflozin, Glimepiride)

Terminated
  • Diabetes Mellitus Type 2
  • Hannover, Germany
    Hannover Medical School
Mar 20, 2019